干扰素治疗对慢性乙肝患者CD4CD25调节性T细胞水平的影响研究.docVIP

干扰素治疗对慢性乙肝患者CD4CD25调节性T细胞水平的影响研究.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
干扰素治疗对慢性乙肝患者CD4CD25调节性T细胞水平的影响研究 目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 文1:干扰素治疗对慢性乙肝患者CD4CD25调节性T细胞水平的影响研究 1 1 资料与方法 3 2 结果 4 3 讨论 6 文2:CD4CD25调节性T细胞与头颈部肿瘤 7 3 TGFβ对CD4+ CD25+ Treg细胞的调节 8 4 VEGF对CD4+CD25+ Treg细胞的调节 10 参考文摘引言: 13 原创性声明(模板) 13 文章致谢(模板) 14 正文 干扰素治疗对慢性乙肝患者CD4CD25调节性T细胞水平的影响研究 文1:干扰素治疗对慢性乙肝患者CD4CD25调节性T细胞水平的影响研究 Effect of CD4+ CD25+ regulatory T cell level of chronic hepatitis B during interferon theraping XUE Haibo1 MA Lili2 LIN Xianfan1 WU Jinming1 Fit Department of Gastroenterology, the Fit Affiliated Hospital of Wenzhou Medical Univeity, Wenzhou 325000, China; of Rheumatology and Immunology, the Fit Affiliated Hospital of Wenzhou Medical Univeity, Wenzhou 325000, China [Abstract] Objective To investigate the changes and clinical significance of peripheral blood regulatory T cells in chronic hepatitis B patients treated with interferon. Methods 60 patients with chronic hepatitis B who were treated with interferon and 20 healthy adults were selected from January 2013 to January 2015 in our hospital. Peripheral blood was collected before treatment and 12th weeks, 24th weeks, 36th weeks, 48th weeks after treatment and 24 weeks after withdrawal, the changes of CD4+CD25+ regulatory T cells (Tregs), serum HBV-DNA and glutamate pyruvate aminotraferase (ALT) in peripheral blood were compared. Results There were no significant differences in the proportion of CD4+CD25+ regulatory T cells, ALT content and HBV-DNA content between complete respoe group, partial respoe group and non respoe group before treatment(P), but they were significantly higher than those in healthy control group, there were statistically significant differences between the groups(P); The proportion of Tregs in the complete respoe group and the partial respoe group after treatment were significantly decreased compared with that before treatment(P); The proportion of Tregs in patients of complete respoe group and partial respoe group had been declining during

文档评论(0)

szbalala + 关注
官方认证
文档贡献者

该用户很懒,什么也没介绍

认证主体深圳市巴啦啦科技有限公司
IP属地广东
统一社会信用代码/组织机构代码
91440300MA5FCP2R75

1亿VIP精品文档

相关文档